Biotech · Private company
NeuroDerm Ltd.
Track this companyFree. Adds NeuroDerm Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- ND0612 Solution for SC infusionPhase 3 · Parkinson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Oral IR-LD/CDPhase 3 · Parkinson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- ND0612Phase 2 · Parkinson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- ND0612 (Levodopa/Carbidopa solution)Phase 2 · Parkinson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- ND0612 (Levodopa/Carbidopa solution) + morning oral IR-LD/CDPhase 2 · Parkinson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor FluctuationsPHASE3 · ACTIVE_NOT_RECRUITING · started Sep 30, 2019ClinicalTrials.gov NCT04006210 · fetched Nov 12, 2026
- A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's DiseasePHASE2 · ACTIVE_NOT_RECRUITING · started May 4, 2016ClinicalTrials.gov NCT02726386 · fetched Nov 12, 2026
- A Clinical Study of Efficacy, Safety, Tolerability and PK of ND0612H in Subjects With Advanced Parkinson's DiseasePHASE2 · COMPLETED · started Dec 29, 2015ClinicalTrials.gov NCT02577523 · fetched Nov 12, 2026